title: [Osteoporosis: diagnosis and treatment of vertebral fractures].
abstract: This review article calls attention of clinicians to under-diagnosed and untreated complication of osteoporosis-osteoporotic vertebral fractures. Usually without clinically significant symptoms, vertebral fractures are very important as an unfavorable prognostic factor of development of osteoporosis. Significant rise of risk of new fractures is observed already in a first year after the fracture. The newest results of the clinical trials of medications for osteoporosis treatment are presented.
authors.affiliation: Kauno medicinos universiteto Reumatologijos klinika, Eiveniu 2, 3007 Kaunas. astai@centras.lt
authors.forename: Asta
authors.initials: A
authors.lastname: Baranauskaite
mesh_terms: D000367:Age Factors; D000368:Aged; D002118:Calcium / Q000008:administration & dosage / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000627:therapeutic use; D012968:Etidronic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D010024:Osteoporosis / Q000150:complications* / Q000517:prevention & control; D010919:Placebos; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D000068296:Risedronic Acid; D012307:Risk Factors; D012737:Sex Factors; D016103:Spinal Fractures / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control; D013997:Time Factors; D014807:Vitamin D / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D002121:Calcium Channel Blockers; D010919:Placebos; D014807:Vitamin D; D000068296:Risedronic Acid; D012968:Etidronic Acid; D002118:Calcium